The Chemotherapy Induced Nausea and Vomiting pipeline guide provides a snapshot of the global therapeutic landscape of Chemotherapy Induced Nausea and Vomiting (Oncology). Learn details of the Global Industry Analysis and Opportunity Assessment H2 2017
- Agency -.
Chemotherapy induced nausea and vomiting or CINV is nausea and vomiting that results specifically from treatment with chemotherapy drugs. The report provides an overview of the Chemotherapy Induced Nausea and Vomiting pipeline (Oncology) pipeline landscape.
Symptoms include a rapid heart rate, sweating, dizziness and increased saliva. Risk factors include age, drug, dose, schedule of administration and route.
- Agency -.
Report Chemotherapy Induced Nausea and Vomiting Pipeline Review, H1 2017 Report at www.reportsnreports.com/contacts/.aspx?name=911506
Companies are Acacia Pharma Ltd, Aphios Corp, Astellas Pharma Inc, Camurus AB, Daewoong Pharmaceutical Co Ltd, Heron Therapeutics Inc, INSYS Therapeutics Inc, Kyowa Hakko Kirin Co Ltd, MannKind Corp, Medlab Clinical Ltd, Nemus Bioscience Inc, RedHill Biopharma Ltd, Serina Therapeutics Inc, SoluBest Ltd, Suda Ltd, Tesaro Inc, Therapix Biosciences Ltd
Access Complete Report On Chemotherapy Induced Nausea and Vomiting Pipeline Review, H2 2017: www.reportsnreports.com/.aspx?name=911506
Chemotherapy Induced Nausea and Vomiting - Drug Profiles : APD-403, aprepitant, Cannabis CINV, dronabinol, FK-886, fosnetupitant, granisetron hydrochloride, LPI-1504, LPI-1505, NB-1222, NB-2111, ondansetron hydrochloride, palmidrol, palonosetron hydrochloride, rolapitant hydrochloride, SER-232, Zindol
The report provides comprehensive information on the therapeutics under development for Chemotherapy Induced Nausea and Vomiting (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Chemotherapy Induced Nausea and Vomiting (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Nausea and Vomiting and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 4, 3, 4, 2, 1, 9, 2 and 1 respectively.
Chemotherapy Induced Nausea and Vomiting (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Category: Market Research Publishers and RetailersCompany profile: ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision-making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets.
For more information: